Skip to the chapter telehealth peptide care A little room for better questions. Open the chapter index Introduction Before choosing care Chapter one The word “peptide” Chapter two An online visit Chapter three People and pharmacies Chapter four Questions to bring Chapter five The whole cost Chapter six Insurance and payment Chapter seven Reasons to pause Chapter eight Follow a source Introduction Follow a source Chapter eight · The reading path # What is the source really saying? A licence record, a medicine approval and a policy document answer different questions. ## Choose a source that matches the question Looking for a licence? Open the state record. Looking for an approval claim? Ask which exact medicine the claim concerns. Looking at a rule about an online visit? Check whether it is a state rule or guidance. Rules checked September 26, 2026 say a medicine or facility may appear in FDA’s register without having the agency’s approval. Keep the question narrow. A source can answer what it covers while leaving your next question open. A word beside the page Scope The particular question a document can answer, along with the limits it states. ## Open a drawer that matches your question. The medicine and its preparation Use FDA’s consumer explanations to separate approval from compounding. A product label concerns a named medicine. FDA — compounding questions and answers FDA — understanding compounded drug concerns FDA — misleading compounding claims FDA — semaglutide (Wegovy) product label The person and the pharmacy Use the directory to reach the relevant board, then read that board’s own record. State medical boards’ group — find a state board FDA — reach a state pharmacy licence search State medical boards’ group — what records disclose The online assessment Read the online-visit guidance written by a group of state boards that license doctors. HHS explains which state must give the doctor permission to treat you. State medical boards’ group — guidance for online visits State medical boards’ group — prescribing guidance HHS — getting started with licensure The price and the insurance route Read the eligibility details and the conditions attached to a published offer. Ask for terms specific to your quote. Government directory — semaglutide (Ozempic) offer CMS — temporary Medicare programme overview CMS — Bridge criteria and covered products CMS — Bridge payment rules Urgent symptoms and medicine reports MedlinePlus explains severe allergic reactions. MedWatch is the FDA route for reporting a medical product problem. MedlinePlus — anaphylaxis FDA — MedWatch ## Read the limits alongside the answer The Federation of State Medical Boards’ online-visit document advises the boards; each state sets the rules its doctors must obey. A pharmacy’s licence record confirms permission to operate, but gives no guarantee that every prescription is filled correctly. Read the date beside a claim. Ask whether the rule still fits the place and product you mean. Bring your state, plan or health history into the question where it matters. A broad phrase can hide the detail you need. A word beside the page The date beside a claim When that information was checked. Rules and offers can change later. Bring it together Return to your questions ← Back to reasons to pause Keep this guide beside your questions; these pages offer neither clinic services nor medicines. Read this chapter as text Text index Back to the chapter top ↑